Other Proteins

The In Vitro Biotinylation Kit (with BirA Tagless Enzyme) is a kit designed for in vitro addition of biotin to biotin-acceptor peptides using BirA. This kit comes in a convenient, easy-to-use format and contains all the components necessary to label biotin-acceptor peptides with biotin. The BirA protein provided is a tagless recombinant biotin protein ligase (EC6.3.4.15). It efficiently catalyzes the specific attachment of biotin to the AviTag™. It is a robust reaction in a wide range of conditions, such as 20-40 µM of protein substrate (biotin-acceptor peptide) concentrations and can tolerate up to 1M NaCl and 20% glycerol in the reaction.

Exedin (9-39) is a GLP-1 (glucagon-like peptide-1) receptor competitive antagonist, with effects on glucose levels.

Exedin (9-39) is a GLP-1 (glucagon-like peptide-1) receptor competitive antagonist, with effects on glucose levels.

Exedin (9-39) is a GLP-1 (glucagon-like peptide-1) receptor competitive antagonist, with effects on glucose levels.

Human SET Recombinant Protein expressed in E. coli with His-tag. Sequence domain: 1-290aa. Application(s): SDS-PAGE.

PROS1, also known as protein S, is a vitamin K-dependent protein that plays a crucial role in the regulation of blood coagulation. It functions as a cofactor for protein C, another key player in the coagulation cascade. PROS1 acts as an anticoagulant by inhibiting the activity of certain clotting factors and promoting the breakdown of blood clots. It helps maintain the balance between clotting and anticoagulation, preventing the formation of excessive blood clots that can lead to thrombosis.

Please note this product may be subject to fees, we invite you to contact your local office. Recombinant human TL1A (TNF-like ligand 1A (also known as Vascular endothelial growth inhibitor, VEGI or TNFSF15), encompassing amino acids 72 to 251(end). This construct contains an N-terminal His-tag (6xHis) followed by an Avi-Tag™. This protein was affinity purified. The protein runs as two bands in SDS-PAGE due to variable glycosylation, as confirmed by PNGase treatment.